Role of primary care in the follow-up of patients with obstructive sleep apnoea undergoing CPAP treatment: a randomised controlled trial

Thorax
M Sánchez-de-la-TorreRespiratory Medicine Research Group

Abstract

To evaluate whether follow-up of patients with obstructive sleep apnoea (OSA) undergoing CPAP treatment could be performed in primary care (PC) settings. Non-inferiority, randomised, prospective controlled study. Sleep unit (SU) at the University Hospital and in 8 PC units in Lleida, Spain. Patients with OSA were randomised to be followed up at the SU or PC units over a 6-month period. The primary outcome was CPAP compliance at 6 months. The secondary outcomes were Epworth Sleep Scale (ESS) score, EuroQoL, patient satisfaction, body mass index (BMI), blood pressure and cost-effectiveness. We included 101 patients in PC ((mean±SD) apnoea-hypopnoea index (AHI) 50.8±22.9/h, age 56.2±11 years, 74% male) and 109 in the SU (AHI 51.4±24.4/h, age 55.8±11 years, 77% male)). The CPAP compliance was (mean (95% CI) 4.94 (4.47 to 5.5) vs 5.23 (4.79 to 5.66) h, p=0.18) in PC and SU groups, respectively. In the SU group, there were greater improvements in ESS scores (mean change 1.79, 95% CI +0.05 to +3.53, p=0.04) and patient satisfaction (-1.49, 95% CI -2.22 to -0.76); there was a significant mean difference in BMI between the groups (0.57, 95% CI +0.01 to +1.13, p=0.04). In the PC setting, there was a cost saving of 60%, with similar effec...Continue Reading

Associated Clinical Trials

References

Apr 29, 1993·The New England Journal of Medicine·T YoungS Badr
Feb 2, 1999·American Journal of Respiratory and Critical Care Medicine·H M EnglemanN J Douglas
Feb 2, 1999·American Journal of Respiratory and Critical Care Medicine·E BallesterJ M Montserrat
Mar 18, 1999·The New England Journal of Medicine·J Terán-SantosJ Cordero-Guevara
Apr 8, 1999·American Journal of Respiratory and Critical Care Medicine·N McArdleN J Douglas
Feb 15, 2000·American Journal of Respiratory and Critical Care Medicine·O ParraJ J Sopeña
Apr 19, 2000·JAMA : the Journal of the American Medical Association·F J NietoT G Pickering
Mar 20, 2001·American Journal of Respiratory and Critical Care Medicine·J DuránA Iztueta
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jul 30, 2004·American Journal of Respiratory and Critical Care Medicine·Juan F MasaJosé M Montserrat
Jan 29, 2008·Archivos de bronconeumología·Miguel Angel Martínez-GarcíaFernando Masa-Jiménez
Feb 6, 2008·Proceedings of the American Thoracic Society·Terri E Weaver, Ronald R Grunstein
Jan 13, 2009·American Journal of Respiratory and Critical Care Medicine·Nick A AnticR Doug McEvoy
Feb 26, 2009·Sleep·Warren R RuehlandAndrew T Thornton
Mar 3, 2009·Progress in Cardiovascular Diseases·Allan I Pack, Thorarinn Gislason
Jun 6, 2009·Respiration; International Review of Thoracic Diseases·Daniel Rodenstein
Dec 17, 2009·American Journal of Respiratory and Critical Care Medicine·Ferran BarbéUNKNOWN Spanish Sleep and Breathing Group
Mar 15, 2011·Archivos de bronconeumología·Patricia LloberesJoaquín Terán-Santos
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Samuel T KunaCharles W Atwood
Jul 2, 2011·The European Respiratory Journal·A L AndreuF Barbé
Mar 14, 2013·JAMA : the Journal of the American Medical Association·Ching Li Chai-CoetzerR Doug McEvoy
Apr 17, 2013·American Journal of Epidemiology·Paul E PeppardKhin Mae Hla

❮ Previous
Next ❯

Citations

Aug 27, 2015·American Journal of Respiratory and Critical Care Medicine·Barbara PhillipsAtul Malhotra
Nov 6, 2015·Chest·Jessica A Cooksey, Jay S Balachandran
Apr 19, 2015·The Lancet. Respiratory Medicine·Ching Li Chai-CoetzerR Doug McEvoy
Oct 19, 2016·Medicina clínica·Manuel Sánchez-de-la-Torre, Ferran Barbé
Jun 17, 2015·Angiology·Sevket Balta, Cengiz Ozturk
May 5, 2017·Journal of the American Geriatrics Society·Andrew M NamenEdward F Haponik
Apr 26, 2018·American Journal of Respiratory and Critical Care Medicine·Samuel T Kuna
Sep 3, 2017·Sleep & Breathing = Schlaf & Atmung·Núria NadalManuel Sánchez-de-la-Torre
Feb 18, 2017·Breathe·Monique SuárezJosep M Montserrat
Feb 1, 2016·Future Hospital Journal·Martyn R Partridge, Noel Baxter
Jan 1, 2017·Expert Review of Precision Medicine and Drug Development·Manuel Sânchez-de-la-Torre, David Gozal
Nov 28, 2019·Annals of the American Thoracic Society·Jean-Louis PépinRenaud Tamisier
Aug 23, 2019·Annals of the American Thoracic Society·Sachin R PendharkarPatrick J Hanly
Apr 14, 2020·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Patricia PeñacobaUNKNOWN PASHOS Working Group
Sep 13, 2019·European Respiratory Review : an Official Journal of the European Respiratory Society·Monique Suarez-GironJosep M Montserrat
Jul 1, 2017·American Journal of Respiratory and Critical Care Medicine·Ching Li Chai-Coetzer, R Doug McEvoy
Apr 18, 2018·American Journal of Respiratory and Critical Care Medicine·M Ángeles Sánchez-QuirogaUNKNOWN Spanish Sleep Network and Primary Care Group
Nov 10, 2020·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Ching Li Chai-CoetzerR Doug McEvoy
Sep 26, 2020·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Sachin R PendharkarKerry A McBrien
Apr 1, 2021·Sleep & Breathing = Schlaf & Atmung·Daniela V PachitoAline Rocha
Aug 25, 2021·Respirology : Official Journal of the Asian Pacific Society of Respirology·Ching Li Chai-Coetzer, Peter R Eastwood
Oct 23, 2019·Chest·Lucas M DonovanVishesh K Kapur

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.